Home Cart 0 Sign in  

[ CAS No. 33421-36-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 33421-36-2
Chemical Structure| 33421-36-2
Structure of 33421-36-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 33421-36-2 ]

Related Doc. of [ 33421-36-2 ]

Alternatived Products of [ 33421-36-2 ]

Product Details of [ 33421-36-2 ]

CAS No. :33421-36-2 MDL No. :MFCD18072507
Formula : C11H9NO Boiling Point : -
Linear Structure Formula :- InChI Key :HPDNGBIRSIWOST-UHFFFAOYSA-N
M.W : 171.20 Pubchem ID :135489221
Synonyms :

Calculated chemistry of [ 33421-36-2 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 51.7
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.03
Log Po/w (XLOGP3) : 2.16
Log Po/w (WLOGP) : 2.45
Log Po/w (MLOGP) : 1.47
Log Po/w (SILICOS-IT) : 2.54
Consensus Log Po/w : 2.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.88
Solubility : 0.226 mg/ml ; 0.00132 mol/l
Class : Soluble
Log S (Ali) : -2.49
Solubility : 0.556 mg/ml ; 0.00325 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.96
Solubility : 0.0187 mg/ml ; 0.000109 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.67

Safety of [ 33421-36-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33421-36-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 33421-36-2 ]
  • Downstream synthetic route of [ 33421-36-2 ]

[ 33421-36-2 ] Synthesis Path-Upstream   1~33

  • 1
  • [ 26482-54-2 ]
  • [ 100-67-4 ]
  • [ 504-29-0 ]
  • [ 51035-40-6 ]
  • [ 33421-36-2 ]
Reference: [1] Chemistry of Heterocyclic Compounds, 1982, vol. 18, # 2, p. 212 - 212
[2] Chemistry of Heterocyclic Compounds, 1982, vol. 18, # 2, p. 212 - 212
  • 2
  • [ 5029-67-4 ]
  • [ 108-95-2 ]
  • [ 51035-40-6 ]
  • [ 33421-36-2 ]
  • [ 98061-22-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1985, vol. 33, # 3, p. 1009 - 1015
  • 3
  • [ 1008-89-5 ]
  • [ 33421-36-2 ]
YieldReaction ConditionsOperation in experiment
75% With oxone; Ru(MesCO2)(4,4'-dibromobipyridine)(p-cymene); trifluoroacetic acid; trifluoroacetic anhydride In 1,2-dichloro-ethane at 140℃; for 8 h; Sealed tube; Green chemistry General procedure: A mixture of 2-arylpyridines (1 eq), Ru(MesCO2)(L) (p-cymene) [L- 2,2’-bypyridine or 4,4’-dibromobipyridine] (5 molpercent), TFA: TFAA=0.6 ml:0.4 ml and Oxone (4 eq) was taken in a 30 ml sealed tube. 1 ml of DCE was added and the tube was then placed in an oil bath, stirred, and heated at 140°C. The progress of the reaction was checked after every 8 hrs. After complete consumption of starting material the reaction mixture was cooled to room temperature, quenched with brine and extracted with dichloromethane. The combined organic layer was dried with anhydrous Na2SO4, and vacuum evaporated. The crude product was purified over a column of silica gel (eluent: hexane/ethyl acetate) to afford the desired products.
67% With water; oxygen In acetonitrile at 130℃; for 36 h; EXAMPLE 1; Synthesis of 2-(pyridine-2-yl)phenol (Ib)In a 20 mL tube, 2-phenylpyridine (0.3 mmol, 1 equiv), Cu(OAc)2 (54.6 mg, 0.3 mmol, 1 equiv) and H2O (5.4 μL, 0.3 mmol, 1 equiv) were dissolved in 1 mL of dry MeCN under * oxygen. The tube was sealed with a Teflon lined cap, and the reaction mixture was stirred at 1300C for 36 h. The reaction mixture was diluted with 20 mL of CH2Cl2 and then treated with 10 mL of saturated Na2S aqueous solution. The mixture was filtered through a pad of Celite, and the filtrate was washed twice with brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. After purification by column chromatography on silica gel with a gradient eluent of hexane and ether (Rf = 0.35 in 2:1 hexane: ether), the title product was obtained as a colorless oil (34.4 mg, 67percent). 1H NMR (400 MHz, CDCl3) δ 14.39 (s, IH), 8.52 (d, J== 4.8 Hz, IH), 7.93 (d, J= 8.4 Hz, IH), 7.87-7.84 (m, IH), 7.81 (d, J= 8.0 Hz, IH), 7.31 (td, J= 7.6, 1.2 Hz, IH), 7.27-7.24 (m, IH), 7.03 (d, J= 8.0 Hz, IH), 6.92 (td, J = 7.6, 1.2 Hz, IH); 13C NMR (100 MHz5 CDCl3) δ 160.29, 158.10, 146.08, 138.05, 131.77, 126.39, 121.79, 119.31, 119.05, 118.89; IR (thin film) v 2923, 1594, 1477, 1270 cm"1; HRMS (TOF) Calcd for CnH10NO (M+ H) 172.0762, found 172.0768.
30% With 18O-labeled water In acetonitrile at 130℃; for 36 h; EXAMPLE 6; Labeling ExperimentIn a 20 mL tube, substrate (0.3 mmol, 1 equiv), Cu(OAc)2 (54.6 mg, 0.3 mmol, 1 equiv) and H218O (5.4 μL, 0.3 mmol, 1 equiv) were dissolved in 1 mL of dry MeCN under N2. The <n="42"/>tube was sealed with a Teflon lined cap, and the reaction mixture was stirred at 130°C for 24 h. The reaction mixture was diluted with 20 mL of CH2CI2 and then treated with 10 mL of saturated Na2S aqueous solution. The mixture was filtered through a pad of Celite, and the filtrate was washed twice with brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. The residue was purified by column chromatography on silica gel (Rf = 0.35, in 2:1 hexane and ether) to give the product in 30percent yield. By the analysis of GC-MS, no I8O-labeled hydroxylated product was detected and only hydroxylated product Ib was obtained.
22% With water; oxygen In dimethyl sulfoxide at 130℃; for 24 h; Hydroxylation by CuF 2In a 20 mL tube, substrate (0.3 mmol, 1 equiv), CuF2 (30.5 mg, 0.3 mmol, 1 equiv) andH2O (27 μL, 1.5 mmol, 5 equiv) were dissolved in 1 mL of dry DMSO under atmospheric air. The tube was sealed with a Teflon lined cap, and the reaction mixture was stirred at1300C for 24 h. The reaction mixture was diluted with 20 mL of CH2Cl2 and then treated <n="39"/>with 10 mL of saturated Na2S aqueous solution. The mixture was filtered through a pad of Celite, and the filtrate was washed twice with brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. The residue was purified by column chromatography on silica gel (Rf = 0.35 in 2:1 hexane: ether), Ib was obtained as a colorless oil (11.2 mg, 22percent).

Reference: [1] ACS Catalysis, 2016, vol. 6, # 9, p. 6050 - 6054
[2] Journal of Organic Chemistry, 2015, vol. 80, # 5, p. 2925 - 2929
[3] Organic Letters, 2017, vol. 19, # 13, p. 3532 - 3535
[4] Tetrahedron Letters, 2017, vol. 58, # 38, p. 3743 - 3746
[5] Angewandte Chemie - International Edition, 2013, vol. 52, # 22, p. 5827 - 5831[6] Angew. Chem., 2013, vol. 125, # 22, p. 5939 - 5943,5
[7] Journal of the American Chemical Society, 2006, vol. 128, # 21, p. 6790 - 6791
[8] Patent: WO2007/123910, 2007, A2, . Location in patent: Page/Page column 27; 37
[9] Organic Letters, 2018, vol. 20, # 18, p. 5533 - 5536
[10] Advanced Synthesis and Catalysis, 2015, vol. 357, # 9, p. 2017 - 2021
[11] Organic Letters, 2018, vol. 20, # 21, p. 6799 - 6803
[12] Organic Letters, 2011, vol. 13, # 24, p. 6536 - 6539
[13] Patent: WO2007/123910, 2007, A2, . Location in patent: Page/Page column 27; 40-41
[14] Patent: WO2007/123910, 2007, A2, . Location in patent: Page/Page column 29-30; 37-38
[15] Synlett, 2013, vol. 24, # 20, p. 2687 - 2690
[16] Organometallics, 2014, vol. 33, # 17, p. 4442 - 4448
[17] Chemical Communications, 2018, vol. 54, # 59, p. 8202 - 8205
  • 4
  • [ 58861-53-3 ]
  • [ 33421-36-2 ]
  • [ 1452876-10-6 ]
Reference: [1] ACS Catalysis, 2016, vol. 6, # 9, p. 6050 - 6054
  • 5
  • [ 5957-89-1 ]
  • [ 33421-36-2 ]
Reference: [1] Synthetic Communications, 2001, vol. 31, # 6, p. 869 - 875
[2] Journal of the Chemical Society, Dalton Transactions: Inorganic Chemistry (1972-1999), 1992, # 23, p. 3345 - 3352
[3] Helvetica Chimica Acta, 1983, vol. 66, # 4, p. 1039 - 1045
[4] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1994, # 7, p. 1603 - 1610
[5] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1990, vol. 26, # 1, p. 65 - 70[6] Khimiya Geterotsiklicheskikh Soedinenii, 1990, # 1, p. 75 - 80
[7] Journal of Materials Chemistry, 1998, vol. 8, # 9, p. 1999 - 2003
[8] Chemical and Pharmaceutical Bulletin, 1985, vol. 33, # 3, p. 1009 - 1015
[9] Chemistry Letters, 2001, # 10, p. 1060 - 1061
[10] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 3, p. 471 - 475
  • 6
  • [ 694-59-7 ]
  • [ 88284-48-4 ]
  • [ 33421-36-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 34, p. 6834 - 6839
[2] Synthesis (Germany), 2015, vol. 46, # 4,
  • 7
  • [ 93953-42-5 ]
  • [ 33421-36-2 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 10, p. 3981 - 3994
[2] Tetrahedron Letters, 1984, vol. 25, # 36, p. 4045 - 4048
  • 8
  • [ 502159-04-8 ]
  • [ 33421-36-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2002, vol. 344, # 8, p. 868 - 883
  • 9
  • [ 694-59-7 ]
  • [ 88284-48-4 ]
  • [ 33421-36-2 ]
  • [ 54168-07-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 34, p. 6834 - 6839
[2] Organic and Biomolecular Chemistry, 2012, vol. 10, # 34, p. 6834 - 6839
  • 10
  • [ 109-04-6 ]
  • [ 33421-36-2 ]
Reference: [1] Chemistry Letters, 2001, # 10, p. 1060 - 1061
[2] Synthetic Communications, 2001, vol. 31, # 6, p. 869 - 875
[3] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1994, # 7, p. 1603 - 1610
[4] Organic Letters, 2018, vol. 20, # 18, p. 5533 - 5536
  • 11
  • [ 694-59-7 ]
  • [ 73501-39-0 ]
  • [ 88284-48-4 ]
  • [ 33421-36-2 ]
  • [ 54168-07-9 ]
  • [ 1394900-26-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 34, p. 6834 - 6839
  • 12
  • [ 58861-53-3 ]
  • [ 33421-36-2 ]
  • [ 1452876-10-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 22, p. 5827 - 5831[2] Angew. Chem., 2013, vol. 125, # 22, p. 5939 - 5943,5
  • 13
  • [ 109-04-6 ]
  • [ 89466-08-0 ]
  • [ 33421-36-2 ]
Reference: [1] Dalton Transactions, 2016, vol. 45, # 45, p. 18365 - 18376
  • 14
  • [ 372492-47-2 ]
  • [ 33421-36-2 ]
  • [ 1452876-71-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 22, p. 5827 - 5831[2] Angew. Chem., 2013, vol. 125, # 22, p. 5939 - 5943,5
[3] ACS Catalysis, 2016, vol. 6, # 9, p. 6050 - 6054
  • 15
  • [ 4203-50-3 ]
  • [ 33421-36-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2002, vol. 344, # 8, p. 868 - 883
  • 16
  • [ 502159-01-5 ]
  • [ 33421-36-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2002, vol. 344, # 8, p. 868 - 883
  • 17
  • [ 1008-89-5 ]
  • [ 33421-36-2 ]
  • [ 4253-81-0 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 24, p. 6536 - 6539
  • 18
  • [ 358741-44-3 ]
  • [ 33421-36-2 ]
Reference: [1] Synthetic Communications, 2001, vol. 31, # 6, p. 869 - 875
  • 19
  • [ 16750-63-3 ]
  • [ 33421-36-2 ]
Reference: [1] Journal of Materials Chemistry, 1998, vol. 8, # 9, p. 1999 - 2003
[2] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1994, # 7, p. 1603 - 1610
[3] Journal of the Chemical Society, Dalton Transactions: Inorganic Chemistry (1972-1999), 1992, # 23, p. 3345 - 3352
  • 20
  • [ 87573-07-7 ]
  • [ 33421-36-2 ]
Reference: [1] Chemistry Letters, 2006, vol. 35, # 8, p. 842 - 843
  • 21
  • [ 533-58-4 ]
  • [ 33421-36-2 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 50, p. 6985 - 6988
[2] Tetrahedron, 2010, vol. 66, # 17, p. 3135 - 3146
  • 22
  • [ 98-80-6 ]
  • [ 33421-36-2 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 18, p. 5533 - 5536
  • 23
  • [ 110-86-1 ]
  • [ 533-58-4 ]
  • [ 33421-36-2 ]
  • [ 54168-07-9 ]
  • [ 86610-20-0 ]
Reference: [1] Heterocycles, 2004, vol. 64, p. 499 - 504
[2] Tetrahedron, 2006, vol. 62, # 33, p. 7824 - 7837
  • 24
  • [ 5720-06-9 ]
  • [ 33421-36-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 3, p. 471 - 475
  • 25
  • [ 93953-41-4 ]
  • [ 33421-36-2 ]
Reference: [1] Tetrahedron Letters, 1984, vol. 25, # 36, p. 4045 - 4048
  • 26
  • [ 1349171-28-3 ]
  • [ 33421-36-2 ]
Reference: [1] Chemical Communications, 2018, vol. 54, # 59, p. 8202 - 8205
  • 27
  • [ 109306-86-7 ]
  • [ 33421-36-2 ]
Reference: [1] Chemical Science, 2017, vol. 8, # 2, p. 946 - 952
  • 28
  • [ 1008-89-5 ]
  • [ 105664-48-0 ]
  • [ 33421-36-2 ]
  • [ 1452876-74-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 22, p. 5827 - 5831[2] Angew. Chem., 2013, vol. 125, # 22, p. 5939 - 5943,5
  • 29
  • [ 90-04-0 ]
  • [ 33421-36-2 ]
Reference: [1] Helvetica Chimica Acta, 1983, vol. 66, # 4, p. 1039 - 1045
  • 30
  • [ 26482-54-2 ]
  • [ 100-67-4 ]
  • [ 504-29-0 ]
  • [ 51035-40-6 ]
  • [ 33421-36-2 ]
Reference: [1] Chemistry of Heterocyclic Compounds, 1982, vol. 18, # 2, p. 212 - 212
[2] Chemistry of Heterocyclic Compounds, 1982, vol. 18, # 2, p. 212 - 212
  • 31
  • [ 109-04-6 ]
  • [ 16750-63-3 ]
  • [ 33421-36-2 ]
Reference: [1] Australian Journal of Chemistry, 1997, vol. 50, # 2, p. 109 - 114
  • 32
  • [ 5029-67-4 ]
  • [ 108-95-2 ]
  • [ 51035-40-6 ]
  • [ 33421-36-2 ]
  • [ 98061-22-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1985, vol. 33, # 3, p. 1009 - 1015
  • 33
  • [ 1008-89-5 ]
  • [ 33421-36-2 ]
  • [ 4253-81-0 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 24, p. 6536 - 6539
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 33421-36-2 ]

Aryls

Chemical Structure| 51035-40-6

[ 51035-40-6 ]

4-(Pyridin-2-yl)phenol

Similarity: 0.92

Chemical Structure| 3308-02-9

[ 3308-02-9 ]

2-Phenylpyridin-3-ol

Similarity: 0.83

Chemical Structure| 187392-96-7

[ 187392-96-7 ]

(5-Phenylpyridin-3-yl)methanol

Similarity: 0.75

Chemical Structure| 1008-89-5

[ 1008-89-5 ]

2-Phenylpyridine

Similarity: 0.74

Chemical Structure| 168823-65-2

[ 168823-65-2 ]

2-(3-Bromo-4-methoxyphenyl)pyridine

Similarity: 0.74

Alcohols

Chemical Structure| 51035-40-6

[ 51035-40-6 ]

4-(Pyridin-2-yl)phenol

Similarity: 0.92

Chemical Structure| 580-16-5

[ 580-16-5 ]

6-Hydroxyquinoline

Similarity: 0.87

Chemical Structure| 3482-14-2

[ 3482-14-2 ]

Isoquinolin-8-ol

Similarity: 0.87

Chemical Structure| 3308-02-9

[ 3308-02-9 ]

2-Phenylpyridin-3-ol

Similarity: 0.83

Chemical Structure| 7651-83-4

[ 7651-83-4 ]

Isoquinolin-7-ol

Similarity: 0.80

Related Parent Nucleus of
[ 33421-36-2 ]

Pyridines

Chemical Structure| 51035-40-6

[ 51035-40-6 ]

4-(Pyridin-2-yl)phenol

Similarity: 0.92

Chemical Structure| 3308-02-9

[ 3308-02-9 ]

2-Phenylpyridin-3-ol

Similarity: 0.83

Chemical Structure| 187392-96-7

[ 187392-96-7 ]

(5-Phenylpyridin-3-yl)methanol

Similarity: 0.75

Chemical Structure| 1008-89-5

[ 1008-89-5 ]

2-Phenylpyridine

Similarity: 0.74

Chemical Structure| 168823-65-2

[ 168823-65-2 ]

2-(3-Bromo-4-methoxyphenyl)pyridine

Similarity: 0.74